Implementations of translational medicine
2005; 3: 33
Immunologic aspect of ovarian cancer and p53 as tumor antigen
2005; 3: 34
The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils
2005; 3: 36
T cell avidity and tumor recognition: implications and therapeutic strategies
2005; 3: 35
Interleukin-1β induced vascular permeability is dependent on induction of endothelial Tissue Factor (TF) activity
2005; 3: 37
Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
2005; 3: 39
The natural history of EGFR and EGFRvIII in glioblastoma patients
2005; 3: 38
Viral load responses to HAART is an independent predictor of a new AIDS event in late stage HIV infected patients: prospective cohort study
2005; 3: 40
CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma
2005; 3: 41
Acquired factor XII deficiency in a woman with recurrent pregnancy loss: working on a differential diagnosis in a single case
2005; 3: 43
Protein kinase activity is associated with CD63 in melanoma cells
2005; 3: 42
Adding pharmacogenomics to the development of new marine-derived anticancer agents
2006; 4: 3
A novel method of modifying immune responses by vaccination with lipiodol-siRNA mixtures
2006; 4: 2
A Phase I Trial of Pox PSA vaccines (PROSTVAC®-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in Patients with Prostate Cancer
2006; 4: 1
Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation
2005; 3: 45
SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling
2005; 3: 44
Why is public science education important?
2006; 4: 7
Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture
2006; 4: 5
Disaggregation and invasion of ovarian carcinoma ascites spheroids
2006; 4: 6
The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells
2006; 4: 9
Chromosomal imbalances in nasopharyngeal carcinoma: a meta-analysis of comparative genomic hybridization results
2006; 4: 4
Hydralazine target: From blood vessels to the epigenome
2006; 4: 10
Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy
2006; 4: 12
Tumor-associated endothelial cells display GSTP1 and RARβ2 promoter methylation in human prostate cancer
2006; 4: 13
The use of microarray technologies in clinical oncology
2006; 4: 8
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance
2006; 4: 11
Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin
2006; 4: 16
An alternative flow cytometry strategy for peripheral blood dendritic cell enumeration in the setting of repetitive GM-CSF dosing
2006; 4: 18
Rewarding patient-directed research: Excellence in Translational Medicine Award
2006; 4: 19
Laser-assisted blastocyst dissection and subsequent cultivation of embryonic stem cells in a serum/cell free culture system: applications and preliminary results in a murine model
2006; 4: 20
Bacteria and cancer: cause, coincidence or cure? A review
2006; 4: 14
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy
2006; 4: 17
Induction of antitumor immunity through xenoplacental immunization
2006; 4: 22
Clonal analysis of palmar fibromatosis: a study whether palmar fibromatosis is a real tumor
2006; 4: 21
Innate immune functions of microglia isolated from human glioma patients
2006; 4: 15
Combined IL-21 and Low-Dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model
2006; 4: 24
Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy
2006; 4: 25
The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection
2006; 4: 23
Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas
2006; 4: 28
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease
2006; 4: 30